SCHEMBL4474923

SCHEMBL4474923

Oc1c[c]cc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.54
▸ NQO2 P16083 1/20 0.48
▸ PTPN22 Q9Y2R2 1/20 0.44
▸ TRPM4 Q8TD43 1/20 0.44
▸ IDO1 P14902 1/20 0.43
▸ POLB P06746 2/20 0.41
▸ HSD17B10 Q99714 3/20 0.40
▸ USP2 O75604 1/20 0.40
▸ PAK1 Q13153 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ TAAR1 Q96RJ0 1/20 0.38
▸ ERN1 O75460 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6632005 0.75 CYP1A2 (0.38) CYP1A2NQO2HSD17B10TDP1TSHR
1-Naphthol SCHEMBL28123317 0.74 CYP1A2 (0.94) CYP1A2NQO2PTPN22TRPM4IDO1
1-Naphthol SCHEMBL28322906 0.74 CYP1A2 (0.94) CYP1A2NQO2PTPN22TRPM4IDO1
SCHEMBL6631223 0.73 IDO1 (0.48) CYP1A2IDO1POLBHSD17B10USP2
SCHEMBL148866 0.73 CYP2A6 (0.52) CYP1A2HSD17B10ALDH1A1TDP1CYP2A6
SCHEMBL2252185 0.73 ALDH1A1 (0.52) CYP1A2NQO2IDO1POLBHSD17B10
SCHEMBL457506 0.73 ALDH1A1 (0.38) CYP1A2NQO2HSD17B10ALDH1A1TDP1
SCHEMBL456099 0.73 ALDH1A1 (0.38) CYP1A2NQO2POLBHSD17B10CYP2C9
SCHEMBL455834 0.73 HPRT1 (0.39) CYP1A2NQO2HSD17B10ALDH1A1TDP1
SCHEMBL455474 0.73 CYP2A6 (0.52) CYP1A2NQO2HSD17B10ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607738-B1 Aqueous solutions of acrylic polymers MIRET LAB (ES) 1997-05-07 — — EP claimed
EP-0607738-A2 Aqueous solutions of acrylic polymers LABORATORIOS MIRET, S.A. (ES) 1994-07-27 — — EP claimed
EP-2952096-B1 Amide compound, an arthropod pest control agent and a method for controlling arthropod pest SUMITOMO CHEMICAL CO (JP) 2018-04-04 — — EP disclosed
US-9814235-B2 Method for controlling arthropod pest SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-14 — — US disclosed
EP-3039014-A1 SUBSTITUTED NAPHTHALENE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS Lupin Atlantis Holdings SA (CH) 2016-07-06 — — EP disclosed
CN-102209541-B Modulators of aldehyde dehydrogenase activity and its using method THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2016-05-18 — — CN disclosed
EP-2952096-A1 METHOD FOR CONTROLLING ARTHROPOD PEST Sumitomo Chemical Company, Limited (JP) 2015-12-09 — — EP disclosed
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-03 — — US disclosed
CN-104955332-A Method for controlling arthropod pest SUMITOMO CHEMICAL CO 2015-09-30 — — CN disclosed
WO-2015028938-A1 SUBSTITUTED NAPHTHALENE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN LIMITED (IN) 2015-03-05 — — WO disclosed
US-20150005348-A1 AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-01-01 — — US disclosed
US-5750681-A Bicyclic beta-lactams and process therefor UNIVERSITY OF NOTRE DAME DU LAC (US) 1998-05-12 — — US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 — — US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 — — CN disclosed
EP-0607738-B1 Aqueous solutions of acrylic polymers MIRET LAB (ES) 1997-05-07 — — EP disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 — — US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 — — EP disclosed
CN-1118781-A Heterocyclic compound with activity against diabetes and preparation and application of same MITSUTAKA CO LTD (JP) 1996-03-20 — — CN disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 — — EP disclosed
EP-0607738-A2 Aqueous solutions of acrylic polymers LABORATORIOS MIRET, S.A. (ES) 1994-07-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344466-A1 METHOD FOR CONTROLLING ARTHROPOD PEST H1-0, H1-3, H1-2 CYP1A2 193/4885NQO2 1067/4885PTPN22 2797/4885
US-20150005348-A1 AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL RPS8, MT-CO2, ARG1 CYP1A2 355/4885NQO2 2706/4885PTPN22 3097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback